日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The evaluation of the plasma levels of interleukin 17A, thymic stromal lymphopoietin, interferon gamma, tumor necrosis factor-alpha and interleukins IL-2, IL-6, IL-23, and IL-31 in atopic dermatitis patients with dupilumab treatment

评估接受度普利尤单抗治疗的特应性皮炎患者血浆中白细胞介素 17A、胸腺基质淋巴细胞生成素、干扰素 γ、肿瘤坏死因子 α 以及白细胞介素 IL-2、IL-6、IL-23 和 IL-31 的水平

Čelakovská, Jarmila; Čermáková, Eva; Boudkova, Petra; Andrýs, Ctirad

Serum IL-13 and IL-31 Levels are not Attenuated upon Dupilumab Treatment: Lessons from a Prospective Cohort

杜普利尤单抗治疗后血清IL-13和IL-31水平并未降低:一项前瞻性队列研究的启示

Suleiman, Ghazal; Boyango, Ilanit; Dawood, Marwan; Mirmovitch-Morvay, Orna; Avitan-Hersh, Emily

Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate-Analyses from the WIL-31 study

长期使用 WIlate 进行预防期间因子 VIII 和血管性血友病因子活性水平的变化——来自 WIL-31 研究的分析

Sidonio, Robert F Jr; Boban, Ana; Djambas Khayat, Claudia

Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis

血浆来源的血管性血友病因子/因子VIII浓缩物(Wilate)预防治疗在3型血管性血友病患者中的疗效和安全性——WIL-31研究亚组分析

Djambas Khayat, Claudia; Dubey, Leonid; Inati, Adlette; Lissitchkov, Toshko; Novik, Dzmitry; Peteva, Elina; Sidonio, Robert F Jr; Taher, Ali T; Vilchevska, Kateryna V; Vdovin, Vladimir; Boban, Ana

Enigmatic Role of IL-31 in the Itch and Inflammation of Vernal Keratoconjunctivitis

IL-31在春季角结膜炎瘙痒和炎症中的神秘作用

Okamoto, Masahiro; Tominaga, Mitsutoshi; Mashimo, Keitaro; Usui-Ouchi, Ayumi; Ebihara, Nobuyuki

IL-4, TSLP and IL-31 Cytokine Profiles as Related to Psychometric Measures in Patients with Mastocytosis

IL-4、TSLP 和 IL-31 细胞因子谱与肥大细胞增生症患者心理测量指标的关系

Romantowski, Jan; Fabiańczyk, Kinga; Skrzypkowska, Maria; Cubała, Wiesław J; Trzonkowski, Piotr; Niedoszytko, Marek

IL-31/33 Axis in Atopic Dermatitis

特应性皮炎中的IL-31/33轴

Łacwik, Julia; Kraik, Krzysztof; Laska, Julia; Tota, Maciej; Sędek, Łukasz; Gomułka, Krzysztof

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis

血浆来源的血管性血友病因子/因子VIII浓缩物(WIlate)预防治疗在儿童和青少年血管性血友病中的疗效和安全性——WIL-31研究事后分析

Sidonio, Robert F Jr; Dubey, Leonid; Vilchevska, Kateryna V; Inati, Adlette; Djambas Khayat, Claudia

Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease-a WIL-31 subanalysis

个体化给药频率可能提高血管性血友病患者的预防效果——一项WIL-31亚组分析

Sidonio, Robert F Jr; Boban, Ana; Lissitchkov, Toshko; Nemes, Laszlo; Vdovin, Vladimir; Khayat, Claudia Djambas

IL-5, IL-31 and systemic immune-inflammation index as biomarkers predicting severity and progression in bullous pemphigoid

IL-5、IL-31 和全身免疫炎症指数作为预测大疱性类天疱疮严重程度和进展的生物标志物

Zhang, Yanyu; Liu, Xia; Hou, Lili; Zhao, Yan; Hao, Jiaxuan; Zhang, Na; Tian, Jing; Li, Xiaoqing; Liu, Zhiyu; Zhou, Hongwei; Xu, Chunyang; Ren, Yuan; Zhou, Haizhou